Cerity Partners LLC Johnson & Johnson Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cerity Partners LLC holds 1,459,080 shares of JNJ stock, worth $213 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

1,459,080

Previous 1,326,891 9.96%

Holding current value

$213 Million

Previous $194 Million 21.92%

% of portfolio

0.53%

Previous 0.51%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $19.2 Million - $22.1 Million	132,189 Added 9.96%	1,459,080 $236 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $5.49 Million - $6 Million	-38,018 Reduced 2.79%	1,326,891 $194 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $36.4 Million - $38.1 Million	-234,310 Reduced 14.65%	1,364,909 $216 Million
Q4 2023 Jan 26, 2024	BUY	$145.6 - $158.88 $100 Million - $109 Million	688,955 Added 75.69%	1,599,219 $251 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $30.4 Million - $34.1 Million	-195,402 Reduced 17.67%	910,264 $142 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $23.9 Million - $25.7 Million	154,730 Added 16.27%	1,105,666 $183 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $20 Million - $23.8 Million	132,117 Added 16.14%	950,936 $147 Million
Q4 2022 Feb 15, 2023	BUY	$160.2 - $179.79 $50.9 Million - $57.1 Million	317,711 Added 63.4%	818,819 $145 Million
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $48,399 - $53,856	-300 Reduced 0.06%	501,108 $81.9 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $35.1 Million - $38.8 Million	208,836 Added 71.38%	501,408 $89 Million
Q1 2022 Apr 25, 2022	SELL	$158.14 - $179.59 $11.8 Million - $13.4 Million	-74,761 Reduced 20.35%	292,572 $49.4 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $19.5 Million - $21.7 Million	125,355 Added 51.8%	367,333 $60.6 Million
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $621,452 - $690,600	-3,848 Reduced 1.57%	241,978 $39.1 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $270,956 - $290,647	-1,699 Reduced 0.69%	245,826 $40.5 Million
Q1 2021 Aug 11, 2021	BUY	$153.07 - $170.48 $20.2 Million - $22.5 Million	131,858 Added 114.0%	247,525 $40.7 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $405,023 - $451,090	-2,646 Reduced 2.24%	115,667 $19 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $945,784 - $1.09 Million	6,898 Added 6.19%	118,313 $18.6 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $5.56 Million - $6.09 Million	39,587 Added 55.11%	111,415 $16.6 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $486,772 - $587,672	-3,779 Reduced 5.0%	71,828 $10.1 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $113,029 - $156,607	-1,017 Reduced 1.33%	75,607 $9.91 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $366,562 - $421,015	2,875 Added 3.9%	76,624 $11.2 Million
Q3 2019 Oct 30, 2019	BUY	$126.95 - $142.14 $947,935 - $1.06 Million	7,467 Added 11.27%	73,749 $9.54 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $460,598 - $506,570	-3,512 Reduced 5.03%	66,282 $9.23 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $695,608 - $773,458	-5,533 Reduced 7.35%	69,794 $9.76 Million
Q4 2018 Feb 06, 2019	SELL	$122.84 - $147.84 $13,758 - $16,558	-112 Reduced 0.15%	75,327 $9.72 Million
Q3 2018 Nov 15, 2018	SELL	$121.58 - $142.88 $49,483 - $58,152	-407 Reduced 0.54%	75,439 $10.4 Million
Q2 2018 Aug 15, 2018	BUY	$119.4 - $131.76 $201,427 - $222,279	1,687 Added 2.27%	75,846 $9.2 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $403,822 - $478,195	-3,228 Reduced 4.17%	74,159 $9.5 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $60,098 - $65,777	-458 Reduced 0.59%	77,387 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $10.1 Million - $10.5 Million	77,845	77,845 $10.1 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Johnson & Johnson Transaction History